ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,544 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentZugAphaia Pharma AG
Aphaia Pharma AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Aphaia Pharma AG is the development and marketing of pharmaceuticals, particularly in the fields of life sciences and biotechnology. The company focuses on the research and development of innovative therapeutics and medications, particularly in the areas of microvascular medicine and the treatment of diseases such as obesity and metabolic disorders.

AI-generated
Offering

Products & services

Industry:Research & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Aphaia Pharma AG

Pharmaceutical Industry
✓ Offered4
Oral glucose formulation (APH-012 / APHD-012)
Oral, coated glucose formulation for targeted release in the small intestine; for the treatment of obesity, prediabetes and other metabolic disorders, currently being evaluated in Phase 2 studies.
Development of precision-driven drug formulations
Development of proprietary, precision-targeted drug formulations with coated beads for the targeted delivery of natural substances to defined segments of the gastrointestinal tract.
Clinical development in obesity
Phase 2 studies in obesity with a placebo-controlled proof-of-concept design; investigation of weight change and other parameters of metabolic diseases.
Clinical development for prediabetes prevention
Phase 2 study in prediabetes to improve glucose tolerance and to assess the potential to prevent type 2 diabetes.
Trust & reputation

ranQ Trust Score of Aphaia Pharma AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Aphaia Pharma AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Aphaia Pharma AG scores 83.4 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.79.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Aphaia Pharma AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Aphaia Pharma AG scores 48.6 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.48.64%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Aphaia Pharma AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Aphaia Pharma AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Aphaia Pharma AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Aphaia Pharma AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Aphaia Pharma AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Bahnhofstrasse 28
6300 Zug

At a glance

Legal form
Corporation
UID
CHE-301.157.491
Founded
2018 · 8 years
Last commercial register change
December 30, 2025
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    GS
    G&L Scientific (Schweiz) GmbH
    Zug
    NT
    Nektar Therapeutics Europe GmbH
    Zug
    NC
    Novotech Clinical Research AG
    Zug
    AI
    Apellis International GmbH
    Zug
    EL
    Earendil Labs AG
    Zug
    PR
    Premier Research Group SA
    Zug
    AS
    Alnylam Switzerland GmbH
    Zug
    CP
    Crinetics Pharmaceuticals Europe GmbH
    Zug